Year |
Citation |
Score |
2017 |
Eure G, Germany R, Given R, Lu R, Shindel AW, Rothney M, Glowacki R, Henderson J, Richardson T, Goldfischer E, Febbo PG, Denes B. Use of a 17-gene prognostic assay in contemporary urologic practice: results of an interim analysis in an observational cohort. Urology. PMID 28454985 DOI: 10.1016/J.Urology.2017.02.052 |
0.303 |
|
2017 |
Lynch JA, Rothney M, Salup R, Ercole CE, Mathur S, Duchene D, Basler JW, Hernandez J, Liss MA, Porter MP, Wright JL, Risk MC, Efimova O, Denes BS, Febbo PG, et al. Treatment patterns after the use of the 17-gene Genomic Prostate Score assay in Veterans newly diagnosed with clinically low-risk prostate cancer. Journal of Clinical Oncology. 35: 54-54. DOI: 10.1200/Jco.2017.35.6_Suppl.54 |
0.338 |
|
2017 |
Salmasi A, Said JW, Raman S, Shindel AW, McCullough D, Bailey H, Rothney M, Marks LS, Febbo PG, Reiter RE. A 17-gene panel for prediction of adverse surgical pathology in the setting of MRI-guided prostate biopsy. Journal of Clinical Oncology. 35: 5063-5063. DOI: 10.1200/Jco.2017.35.15_Suppl.5063 |
0.316 |
|
2016 |
Lynch JA, Rothney M, Salup R, Ercole CE, Mathur S, Duchene D, Basler JW, Hernandez J, Liss MA, Porter MP, Wright JL, Risk MC, Garzotto M, Efimova O, Kemeter MJ, et al. Improving risk stratification among veterans with newly diagnosed, clinically low-risk prostate cancer using the 17-gene genomic prostate score assay. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E16611 |
0.316 |
|
2016 |
Bonham M, Nightingale B, Tharayanil A, Denes BS, Rothney M, McCullough D, Bennett J, Febbo PG, Tsiatis AC. Association of PSA and number of cores positive with likelihood of adverse pathology at radical prostatectomy based on a 17-gene expression assay. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E16570 |
0.315 |
|
2016 |
Stemmer S, Steiner M, Rizel S, Soussan-Gutman L, Geffen D, Nisenbaum B, Ben-Baruch N, Isaacs K, Fried G, Rosengarten O, Uziely B, Svedman C, Rothney M, Klang S, Ryvo L, et al. Abstract P5-08-02: Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98% Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-08-02 |
0.301 |
|
2015 |
Sasai H, Brychta RJ, Wood RP, Rothney MP, Zhao X, Skarulis MC, Chen KY. Does Visceral Fat Estimated by Dual-Energy X-ray Absorptiometry Independently Predict Cardiometabolic Risks in Adults? Journal of Diabetes Science and Technology. 9: 917-24. PMID 25802470 DOI: 10.1177/1932296815577424 |
0.525 |
|
2015 |
Knezevic D, Lu R, Burke E, Rothney M, Zhang N, Febbo PG, Lawrence HJ. Evaluation of the contribution of individual gene groups to a 17-gene prognostic prostate cancer signature. Journal of Clinical Oncology. 33: 101-101. DOI: 10.1200/Jco.2015.33.7_Suppl.101 |
0.308 |
|
2015 |
Dall'Era MA, Denes B, Lawrence HJ, Tsiatis AC, Rothney M, Maddala T, Febbo PG, Badani K. Clinical utility of a 17-gene genomic prostate score (GPS) for treatment selection in men with newly diagnosed prostate cancer (PCa). Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E16124 |
0.313 |
|
2015 |
Badani KK, Kemeter MJ, Febbo PG, Lawrence HJ, Denes BS, Rothney MP, Rothberg MB, Brown GA. The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance Urology Practice. 2: 181-189. DOI: 10.1016/J.Urpr.2014.10.010 |
0.334 |
|
2013 |
Rothney MP, Catapano AL, Xia J, Wacker WK, Tidone C, Grigore L, Xia Y, Ergun DL. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors. Obesity (Silver Spring, Md.). 21: 1798-802. PMID 23696250 DOI: 10.1002/Oby.20223 |
0.328 |
|
2013 |
Rothney MP, Xia Y, Wacker WK, Martin FP, Beaumont M, Rezzi S, Giusti V, Ergun DL. Precision of a new tool to measure visceral adipose tissue (VAT) using dual-energy X-Ray absorptiometry (DXA). Obesity (Silver Spring, Md.). 21: E134-6. PMID 23505194 DOI: 10.1002/Oby.20140 |
0.35 |
|
2013 |
Ergun DL, Rothney MP, Oates MK, Xia Y, Wacker WK, Binkley NC. Visceral adipose tissue quantification using Lunar Prodigy. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 16: 75-8. PMID 23148876 DOI: 10.1016/J.Jocd.2012.09.002 |
0.363 |
|
2012 |
Rothney MP, Martin FP, Xia Y, Beaumont M, Davis C, Ergun D, Fay L, Ginty F, Kochhar S, Wacker W, Rezzi S. Precision of GE Lunar iDXA for the measurement of total and regional body composition in nonobese adults. Journal of Clinical Densitometry : the Official Journal of the International Society For Clinical Densitometry. 15: 399-404. PMID 22542222 DOI: 10.1016/J.Jocd.2012.02.009 |
0.306 |
|
2012 |
Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, Ergun DL. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring, Md.). 20: 1313-8. PMID 22282048 DOI: 10.1038/Oby.2011.393 |
0.34 |
|
2012 |
Heil DP, Brage S, Rothney MP. Modeling physical activity outcomes from wearable monitors. Medicine and Science in Sports and Exercise. 44: S50-60. PMID 22157775 DOI: 10.1249/Mss.0B013E3182399Dcc |
0.305 |
|
2010 |
Rothney MP, Brychta RJ, Meade NN, Chen KY, Buchowski MS. Validation of the ActiGraph two-regression model for predicting energy expenditure. Medicine and Science in Sports and Exercise. 42: 1785-92. PMID 20142778 DOI: 10.1249/Mss.0B013E3181D5A984 |
0.518 |
|
2010 |
Sevinsky C, Dinn S, Pang Z, Li Q, Sarachon B, Rothney M, Colligan B, Douglass L, Carter J, Graff J, Ginty F. Abstract A28: Multiplexed immunofluorescence in formalin-fixed paraffin-embedded prostate cancer Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-A28 |
0.302 |
|
2009 |
Brychta RJ, Rothney MP, Skarulis MC, Chen KY. Optimizing energy expenditure detection in human metabolic chambers. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 6864-8. PMID 19964185 DOI: 10.1109/IEMBS.2009.5333121 |
0.424 |
|
2009 |
Rothney MP, Brychta RJ, Schaefer EV, Chen KY, Skarulis MC. Body composition measured by dual-energy X-ray absorptiometry half-body scans in obese adults. Obesity (Silver Spring, Md.). 17: 1281-6. PMID 19584885 DOI: 10.1038/Oby.2009.14 |
0.486 |
|
2009 |
Rothney M, Chen K. Reply to Brage, Van Hees, and Brage Journal of Applied Physiology. 106: 1474-1475. DOI: 10.1152/Japplphysiol.00048.2009 |
0.419 |
|
2008 |
Rothney MP, Apker GA, Song Y, Chen KY. Comparing the performance of three generations of ActiGraph accelerometers. Journal of Applied Physiology (Bethesda, Md. : 1985). 105: 1091-7. PMID 18635874 DOI: 10.1152/Japplphysiol.90641.2008 |
0.503 |
|
2008 |
Rothney MP, Schaefer EV, Neumann MM, Choi L, Chen KY. Validity of physical activity intensity predictions by ActiGraph, Actical, and RT3 accelerometers. Obesity (Silver Spring, Md.). 16: 1946-52. PMID 18535553 DOI: 10.1038/Oby.2008.279 |
0.542 |
|
2007 |
Chen KY, Rothney MP, Brychta RJ. Physical activity monitors: do more sensors mean better precision? Journal of Diabetes Science and Technology. 1: 768-70. PMID 19885146 DOI: 10.1177/193229680700100523 |
0.535 |
|
2007 |
Rothney MP, Neumann M, Béziat A, Chen KY. An artificial neural network model of energy expenditure using nonintegrated acceleration signals. Journal of Applied Physiology (Bethesda, Md. : 1985). 103: 1419-27. PMID 17641221 DOI: 10.1152/Japplphysiol.00429.2007 |
0.523 |
|
2006 |
Rothney MP, Neumann MM, Chen KY. Physical Activity Type Identification Using Tri-Axial Accelerometry Medicine & Science in Sports & Exercise. 38: S560. DOI: 10.1249/00005768-200605001-03203 |
0.466 |
|
2006 |
Neumann MM, Rothney MP, Chen KY. Effect of Lead Placement on Activity Measurement, and Energy Expenditure Prediction Using the Actiheart™ Logger Medicine & Science in Sports & Exercise. 38: S556. DOI: 10.1249/00005768-200605001-03188 |
0.533 |
|
Show low-probability matches. |